September 19, 2014 12:18 PM ET

Biotechnology

Company Overview of Open Monoclonal Technology, Inc.

Executive Profile

Keitaro Yoshida

Member of Scientific Advisory Board, Open Monoclonal Technology, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. V. Keitaro Yoshida, also known as Dick, served as President's Special Assistant for Corporate Management and Development of Daiichi Pharmaceuticals from 1990 to 2005. Mr. Yoshida has been actively involved in the pharmaceutical and diagnostics areas for over 50 years. He joined Daiichi Pharmaceuticals in 1967 and served as Deputy General Manager of Corporate Planning, International Department, Research and Development and also served as its General Manager of Corporate ...

Corporate Headquarters

2747 Ross Road
Palo Alto, California 94303

United States

Phone: 650-224-6835
Fax: 866-591-1712

Board Members Memberships

Director

Education

Unknown/Other Education 1951
Faculty of Science and Technology, Keio University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Open Monoclonal Technology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.